What impresses me about working with iteratec is their willingness to take risks to find innovative solutions whilst keeping feasibility in mind. Competent teams who enjoy their work and have the courage to question things are what make project work with iteratec a success.
BIOSEET
How bioseet brings development partners together on its virtual marketplace
A revolution in pharmaceutical partnering
bioseet is a start-up in the pharmaceutical sector whose vision is to revolutionise the partnering process between companies in the context of drug development. With its digital platform for searching for and evaluating development partners and investment opportunities in the fields of innovative medicines, biosimilars and generics, the company aims to replace traditional partnering conferences and face-to-face networking. Instead, start-ups, established manufacturers and investors can search efficiently and effectively for interesting opportunities via a virtual marketplace.
The advantage: thanks to a mutual opt-in mechanism in the partnering process, initial contact is made completely anonymously. Only once both parties have given their consent and the relevant NDAs have been signed are their identities revealed.
Founded in 2019, bioseet is one of the largest partnering platforms in the biotech market, with more than 250 active companies on the platform.
Comprehensive security architecture to protect intellectual property
A key aspect of the platform is the anonymity and confidentiality between the parties involved. In order to reliably protect intellectual property on the platform and to strengthen the participating companies’ trust in the platform, iteratec developed a comprehensive security concept based on the CIA2 principle. This provides for dedicated measures to ensure the confidentiality and availability of the platform, as well as the integrity and authenticity of the data and its users (see figure).
The security architecture is designed in such a way that the individual layers of the platform are isolated from one another to ensure multi-tenancy, and are protected against unauthorised data leakage through encrypted communication and secure access points. Furthermore, threat analyses and code reviews were carried out at various stages of the development process to rule out any security vulnerabilities. To ensure compliance with European and German data protection standards, care was taken when selecting the cloud infrastructure to ensure that the data is hosted exclusively in Germany.
Teamspace with its own user management system
In addition to ensuring confidentiality and anonymity during the initial contact phase, the bioseet platform offers new opportunities compared to traditional partnering conferences to make the internal evaluation process more effective and efficient. For example, companies can invite various internal experts and stakeholders within their Teamspace to evaluate interesting business opportunities as a team and jointly negotiate the terms of potential collaborations.
To this end, iteratec implemented its own user group management system as well as additional features, such as a comments and notifications function, which support efficient communication within the team and thus help to shorten the time taken to close a deal.
Digital champion in the pharmaceutical sector
The platform has now established itself as a marketplace for innovative medicines, biosimilars and generic medicines, with a total of more than 500 completed transactions to date. bioseet is therefore not only the first virtual partnering platform for this type of medicinal product, but also, with a market share of around 70 per cent, the leading provider in the field of digital marketplaces for research collaborations.
iteratec supported this journey from visionary start-up to digital champion over several years. The flexible microservices architecture ensures the continuous expandability of the platform’s functionality and its sustainable scalability.
